Ontology highlight
ABSTRACT:
SUBMITTER: Cross NC
PROVIDER: S-EPMC5240017 | biostudies-literature | 2016 Sep
REPOSITORIES: biostudies-literature
Cross N C P NC White H E HE Ernst T T Welden L L Dietz C C Saglio G G Mahon F-X FX Wong C C CC Zheng D D Wong S S Wang S-S SS Akiki S S Albano F F Andrikovics H H Anwar J J Balatzenko G G Bendit I I Beveridge J J Boeckx N N Cerveira N N Cheng S-M SM Colomer D D Czurda S S Daraio F F Dulucq S S Eggen L L El Housni H H Gerrard G G Gniot M M Izzo B B Jacquin D D Janssen J J W M JJ Jeromin S S Jurcek T T Kim D-W DW Machova-Polakova K K Martinez-Lopez J J McBean M M Mesanovic S S Mitterbauer-Hohendanner G G Mobtaker H H Mozziconacci M-J MJ Pajič T T Pallisgaard N N Panagiotidis P P Press R D RD Qin Y-Z YZ Radich J J Sacha T T Touloumenidou T T Waits P P Wilkinson E E Zadro R R Müller M C MC Hochhaus A A Branford S S
Leukemia 20160425 9
Molecular monitoring of chronic myeloid leukemia patients using robust BCR-ABL1 tests standardized to the International Scale (IS) is key to proper disease management, especially when treatment cessation is considered. Most laboratories currently use a time-consuming sample exchange process with reference laboratories for IS calibration. A World Health Organization (WHO) BCR-ABL1 reference panel was developed (MR(1)-MR(4)), but access to the material is limited. In this study, we describe the de ...[more]